Study: Neanderthals cared for children with Down syndrome

Updated July 11, 2024, Published July 7, 2024 – By Editorial staff
"The excavations at Cova Negra have been key to understanding the way of life of the Neandertals along the Mediterranean coast of the Iberian Peninsula", scientists say.

The remains of a six-year-old Neanderthal child who likely suffered from Down syndrome have been found in Spain. The findings suggest that the child received extensive care from his group, indicating a high level of compassion among Neanderthals.

Neanderthals (Homo neanderthalensis) lived from about 400,000 years ago to about 40,000 years ago. Basically, they lived in the western parts of Asia and Europe.

In the Cova Negra cave in the Valencia region of eastern Spain, fossils were found that, after analysis, are believed to be Neanderthal. They also found a child with a severely deformed bone in its inner ear, which is associated with Down syndrome.

The researchers estimate that the child, named Tina, was six years old when she died, according to the findings published in the journal Science Advances. She likely had severe hearing loss and problems with balance and dizziness.

Neanderthals have long been known to care for the sick or injured, but interest in understanding the meaning of this behavior has grown in recent years. One theory is that they were kind in a transactional sense, helping adult individuals in return for the favor. But another theory is that they did it out of pure compassion, which is what this study suggests, the researchers say.

Needed lots of care

The child would have needed a lot of care, and life for a Neanderthal was hard, so the researchers suggest that the whole group probably helped to care for the child. However, children are not able to return the favor like an adult, suggesting that the child was cared for out of compassion.

"This is a known case in Neanderthals of social care for a child with a severe pathology", writes the research team from the University of Alcalá and the University of Valencia in Spain, together with Binghamton University and the State University of New York.

The other children with Down syndrome found in prehistoric times died in infancy, making this finding unusual. This suggests that the child must have been cared for around the clock.

– The excavations at Cova Negra have been key to understanding the way of life of the Neandertals along the Mediterranean coast of the Iberian Peninsula and have allowed us to define the occupations of the settlement: of short temporal duration and with a small number of individuals, alternating with the presence of carnivores, said Professor Valentín Villaverde of the University of Valencia in a press release.

In contrast, there is a documented case in which a chimpanzee with Down syndrome survived for almost two years due to the care of its mother and sister. It was only when the chimpanzee's sister stopped caring for the baby that things became too difficult for the mother, and the baby died.

The researchers stress that they cannot say for sure that the infant had Down syndrome, but that the findings strongly suggest that it did.

TNT is truly independent!

We don’t have a billionaire owner, and our unique reader-funded model keeps us free from political or corporate influence. This means we can fearlessly report the facts and shine a light on the misdeeds of those in power.

Consider a donation to keep our independent journalism running…

Powerful new antibiotic discovered by accident

Published November 6, 2025 – By Editorial staff

Researchers have discovered an antibiotic that is more than 100 times stronger than previously thought – by studying a process that has been known for at least fifty years. The discovery could be a breakthrough in the fight against antibiotic-resistant bacteria.

Antibiotics were discovered in 1928 by Alexander Fleming, but widespread use of the drug only began during World War II. Today, large amounts of antibiotics are used annually worldwide, which has led to higher resistance to the drug.

Antimicrobial resistance (AMR) means that bacteria, viruses, fungi and parasites develop resistance to drugs, including antibiotics. It arises primarily through incorrect and excessive use of antibiotics, and is a problem that is increasing globally. It is therefore considered one of the most serious threats to global health.

Now researchers at the University of Warwick in the UK and Monash University in Australia have made an unexpected discovery while studying how the bacterium Streptomyces coelicolor produces the old antibiotic methylenomycin A. This bacterium has been one of the most studied in antibiotic research since the 1950s.

In simple terms, when cells produce chemical substances, they go through several intermediate stages before the final product is ready – rather like baking, where ingredients are mixed in a certain order. The researchers had the idea of testing these intermediate stages for antimicrobial activity. It turned out that one of them is significantly more powerful than the final product itself.

Methylenomycin A was originally discovered 50 years ago and while it has been synthesized several times, no-one appears to have tested the synthetic intermediates for antimicrobial activity!, says Professor Greg Challis at the University of Warwick, in a press release.

One hundred times more powerful

This intermediate stage, called pre-methylenomycin C lactone, proved to be a very powerful antibiotic – in fact one hundred times more effective than methylenomycin A against dangerous bacteria. It worked particularly well against bacteria that cause MRSA (methicillin-resistant staphylococcus infection) and VRE (vancomycin-resistant enterococci) – two of healthcare's worst nightmares.

Furthermore, the bacteria appeared to have great difficulty developing resistance to the new antibiotic. The discovery opens up a completely new avenue for antibiotic research, and the researchers have already developed a new method for producing the antibiotic in larger quantities, with preclinical trials as the next step.

This discovery suggests a new paradigm for antibiotic discovery. By identifying and testing intermediates in the pathways to diverse natural compounds, we may find potent new antibiotics, says Professor Challis.

“Eco-friendly” cattle feed may have negative climate impact

The exaggerated climate crisis

Published November 3, 2025 – By Editorial staff
Algae have been presented as "the solution" to methane emissions from cows, but the entire production chain paints a completely different picture.

Algae in cattle feed has been presented as a breakthrough in the fight against methane emissions from livestock. But new Swedish research shows that the real climate benefit may be minimal – or even negative. Energy-intensive production and long-distance transport risk canceling out any environmental gains achieved in the barn.

As climate alarmism has risen, cows have increasingly been accused of being real climate villains due to the methane emissions that occur when they burp and pass gas – which is why various schemes have emerged to solve this so-called problem. In 2022, for example, Prince Charles praised the British startup company Zelp for inventing a mask for cows to wear that would convert methane gas into water vapor. The cow mask is still under development but may likely become part of British cows' daily life.

However, the most talked-about solution has been the methane-reducing supplements implemented in cattle feed. The best known is Bovaer, which the Swedish-Danish dairy cooperative Arla has particularly been criticized for using, with both Danes and Swedes calling for a boycott of the company. Due to the strong criticism, the company is planning further studies to see how it affects cows' health, as well as the meat and milk.

Algae has been described as climate-smart

Another supplement being tested for cows is algae, which according to some studies has been shown to reduce methane emissions by between 30 and 90 percent. Now, however, research from KTH Royal Institute of Technology in Stockholm has shown that these figures may be highly misleading.

Adding algae to cattle feed has been overestimated as a quick solution to livestock emissions, says Jean-Baptiste Thomas, researcher at the Division of Water and Environmental Engineering at KTH, in a press release.

To measure climate impact, one must take into account how these algae are produced, processed, and how far they are transported. The algae are often dried or refined, which involves energy-intensive methods such as freeze-drying. Furthermore, there is of course an environmental impact when fossil fuels are used, Thomas argues.

Sometimes there is no climate benefit at all

The most common algae used is Asparagopsis, which has the greatest effect on methane emissions, but it is a tropical species. This means long-distance transport all the way to Sweden. Growing it locally in Sweden is not a good alternative either, as it would require artificial, energy-intensive land-based cultivation systems since the species is invasive.

The real climate benefit is much smaller – and sometimes there is no benefit at all, or it can even be worse, says Thomas.

Thomas still believes that algae can be of some use as a supplement in cattle feed, as long as the environmental impact is low. For example, it could be interesting to use by-products instead, but he emphasizes that algae alone cannot "transform the climate footprint of livestock". This study is the first to look at the entire chain for algae feed, something that surprises the researchers.

It's quite surprising, considering how much attention the issue has received for almost a decade. Perhaps it shows how eager we are to find quick technical solutions to the climate crisis, says Thomas.

Increased cancer risk linked to covid vaccines

The criticized covid vaccinations

Published November 1, 2025 – By Editorial staff
The overall risk of cancer diagnosis increased by 27 percent compared to those who had not received the COVID-19 vaccine.

A comprehensive South Korean study shows a correlation between covid vaccines and increased cancer incidence, particularly prostate cancer and lung cancer.

However, the researchers are cautious in their conclusions and careful to point out that the statistical correlations do not constitute proof of any causal relationship.

In the study, which has been published in Biomarker Research, researchers examined data from 8,407,849 people between 2021 and 2023, drawn from the Korean National Health Insurance Database. The participants were divided into two groups depending on whether they had received covid vaccines or not. The aim was to examine both the actual occurrence (incidence) of cancer and subsequent cancer risks one year after vaccination.

The results show that there were indications of increased risks for various cancer types one year after receiving any form of covid vaccine, compared to those who had not received it. The overall risk of cancer diagnosis increased by 27 percent compared to those who had not received covid vaccines.

Regarding specific cancer forms, the most pronounced risk increases were seen for prostate cancer, which increased by 69 percent, followed by lung cancer which increased by 53 percent. Furthermore, the risk of thyroid cancer increased by 35 percent and stomach cancer by 34 percent. Colorectal cancer showed a risk increase of 28 percent, while breast cancer increased by 20 percent.

These risk increases applied to diagnoses made within one year after vaccination, regardless of whether mRNA or non-mRNA vaccines were used. However, it is unclear which covid vaccines were included in the study.

Statistical correlations

The researchers emphasize, however, that the study's results do not provide evidence that covid vaccines cause cancer, but rather that these are "statistical correlations".

One possible explanation could be, for example, that covid-vaccinated individuals have likely undergone more medical check-ups and screenings, which increases the chance of detecting cancer early compared to those who have not received covid vaccines. However, one cannot say with certainty what causes this, only that there is a difference depending on covid vaccination status.

Study: Testosterone does not control men’s economic risk-taking

Published October 25, 2025 – By Editorial staff
The researchers tested nine different economic behaviors – from risk-taking to generosity – but found no difference between the groups.

Testosterone has no effect on men's economic decisions, according to the largest study to date in this field. One thousand Canadian men who received testosterone made the same decisions as those who received a placebo – a result that challenges previous research.

In the study, published in the scientific journal PNAS, 1,000 Canadian men aged 18 to 45 participated. The men were randomly assigned to receive either an 11-milligram dose of testosterone or a placebo in a double-blind study. Once the hormone began to take effect, the men participated in various experiments to measure risk-taking, generosity, competitiveness, and fairness preferences.

A total of nine different outcomes were measured, and the results showed that both groups behaved on average in the same way, regardless of whether they received testosterone or placebo – across all outcomes.

Our results provide strong evidence that short-term increases in testosterone have no meaningful impact on men's economic decisions, says Anna Dreber Almenberg, professor at the Department of Economics at the Stockholm School of Economics in Sweden, in a press release.

Largest study in the field

Previous studies have suggested that testosterone can influence the propensity to take risks or compete in economic situations, but this study shows that this is not necessarily the case. This study is also the largest of its kind in the field, with ten to twenty times more men participating than in previous studies.

However, the researchers emphasize that they only tested one dose and one time perspective in the men, which means that other possible effects could occur at different doses or time perspectives. Women were also not included in the trial.

The study is important because it directly challenges the idea that short-term fluctuations in testosterone levels explain why some people take greater economic risks, reject unfair offers, or act more competitively in life, says Justin M. Carré, professor at the Faculty of Arts and Science at Nipissing University in Canada.